For Ever has entered into a strategic partnership with Synergia Capital Partners
For Ever, the global market leader in gladiolus breeding, has entered into a strategic partnership with Synergia Capital Partners B.V. With this investment, the company will continue the strong growth of recent years.
Based in the Netherlands, For Ever was established in 1998, when three gladiolus breeders brought their genetics into one company. The merger aimed to create economies of scale, which has resulted in the company’s current dominant position in the sector. Breeding is the process of developing and producing new plant species. For Ever has developed unique gladiolus varieties that are appreciated by its customers all over the world. On the back of its number one position, For Ever is well positioned to benefit from the current market dynamics and increase its market share.
Synergia Capital Partners is an investment company funded by successful Dutch entrepreneurs which invests in companies based on the premise that a combination of knowledge and capital will lead to success. One of their focus sectors is agriculture, and with a strong track record within the space, Synergia is believed to have the right capabilities and experience to support For Ever in realizing its strategic goals.
Oaklins’ team in the Netherlands served as the exclusive sell-side advisors to For Ever in this transaction.
Theo van Aanholt
Director, For Ever
Talk to the deal team
Frank de Hek
Casper Oude Essink
Associate DirectorAmsterdam, Netherlands
Permali Gloucester has been acquired by Diamorph (subject to regulatory approval)
Private equity firm 3i Group and the private shareholders of Permali Gloucester Limited have sold their interest in the company to Diamorph.Learn more
BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher
BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.Learn more
Paaschburg & Wunderlich GmbH has been acquired by Bihr N.V.
The shareholders of Paaschburg & Wunderlich GmbH (P&W) have sold 100% of their shares to Bihr N.V.Learn more